Sutro Biopharma, Inc.
Biotechnology company · South San Francisco, California, United States · Nasdaq: STRO
Sutro Biopharma, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its shares trade on Nasdaq under the ticker STRO. It has reported private securities offerings to the US SEC, most recently $85 million sold in a notice filed in 2018.
Sutro Biopharma at a glance
What does Sutro Biopharma do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $85.4 million sold (2018).
Frequently asked questions about Sutro Biopharma
Where is Sutro Biopharma headquartered?
Sutro Biopharma, Inc. is headquartered in South San Francisco, California, United States.
What does Sutro Biopharma do?
Sutro Biopharma, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Sutro Biopharma a public company?
Yes. Sutro Biopharma, Inc. trades on Nasdaq under the ticker STRO.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Electra Therapeutics, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.